Skip to main content
Top

2018 | OriginalPaper | Hoofdstuk

22. Medicatieafbouw

Minder is vaak meer

Auteur : Rob van Marum

Gepubliceerd in: De dokter en de dood

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Mevrouw Jansen, 90 jaar oud, is enkele weken geleden opgenomen geweest op de afdeling interne geneeskunde van het nabijgelegen ziekenhuis in verband met een longontsteking.
Literatuur
1.
go back to reference Geijteman E, Arevalo J, Huisman B, et al. Minder medicijnen in de laatste levensfase. Med Contact. 2014;14:721-723. Geijteman E, Arevalo J, Huisman B, et al. Minder medicijnen in de laatste levensfase. Med Contact. 2014;14:721-723.
2.
go back to reference Stevenson J, Abernethy AP, Miller C, et al. Managing comorbidities in patients at the end of life. Review. Br Med J. 2004;329(7471):909-912. Stevenson J, Abernethy AP, Miller C, et al. Managing comorbidities in patients at the end of life. Review. Br Med J. 2004;329(7471):909-912.
3.
go back to reference Nordennen RT van, Lavrijsen JC, Vissers KC, Koopmans RT. Decision making about change of medication for comorbid disease at the end of life: an integrative review. Drugs Aging. 2014;31:501-512. Nordennen RT van, Lavrijsen JC, Vissers KC, Koopmans RT. Decision making about change of medication for comorbid disease at the end of life: an integrative review. Drugs Aging. 2014;31:501-512.
4.
go back to reference Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliative Care. 2011;19:15-21. Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliative Care. 2011;19:15-21.
5.
go back to reference Raijmakers NJ, Zuylen L van, Furst CJ, et al. Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer. 2013;21:1003-1011. Raijmakers NJ, Zuylen L van, Furst CJ, et al. Variation in medication use in cancer patients at the end of life: a cross-sectional analysis. Support Care Cancer. 2013;21:1003-1011.
6.
go back to reference Currow DC, Stevenson JP, Abernethy AP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590-595. Currow DC, Stevenson JP, Abernethy AP, et al. Prescribing in palliative care as death approaches. J Am Geriatr Soc. 2007;55(4):590-595.
7.
go back to reference Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliative Med. 2005;8:876-881. Vollrath AM, Sinclair C, Hallenbeck J. Discontinuing cardiovascular medications at the end of life: lipid-lowering agents. J Palliative Med. 2005;8:876-881.
8.
go back to reference Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn Polyfarmacie bij ouderen. Utrecht: nhg; 2012. Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn Polyfarmacie bij ouderen. Utrecht: nhg; 2012.
9.
go back to reference Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Review. Br J Clin Pharmacol. 2004;57:6-14. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Review. Br J Clin Pharmacol. 2004;57:6-14.
10.
go back to reference Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605-609. Holmes HM, Hayley DC, Alexander GC, et al. Reconsidering medication appropriateness for patients late in life. Arch Intern Med. 2006;166:605-609.
11.
go back to reference Kuijpers MAJ, Marum RJ van, Egberts ACG, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65:130-133. Kuijpers MAJ, Marum RJ van, Egberts ACG, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65:130-133.
12.
go back to reference Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648-1654. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648-1654.
13.
go back to reference Vermeulen Windsant-van den Tweel AM, Verduijn M, Derijks J, et al. stopp/start criteria: een nieuwe standaard voor detectie van ongewenst geneesmiddelgebruik bij ouderen? Ned Tijdschr Geneeskd. 2011;155(36):A3802. Vermeulen Windsant-van den Tweel AM, Verduijn M, Derijks J, et al. stopp/start criteria: een nieuwe standaard voor detectie van ongewenst geneesmiddelgebruik bij ouderen? Ned Tijdschr Geneeskd. 2011;155(36):A3802.
14.
go back to reference American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-631. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-631.
Metagegevens
Titel
Medicatieafbouw
Auteur
Rob van Marum
Copyright
2018
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2060-8_22